EQS-News: Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
Issuer: Mainz BioMed N.V. / Key word(s): Study results Mainz Biomed Presents Groundbreaking Results of ColoFuture Study ...
Stay updated with breaking news from Moritz Eidens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Mainz BioMed N.V. / Key word(s): Study results Mainz Biomed Presents Groundbreaking Results of ColoFuture Study ...
Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in the fight against pathogens. The world learned about messenger RNA molecules and their flexibility, speed and power during the COVID-19 battle. Although this virus is still present, mRNA vaccines helped the world cope with this unprecedented health challenge and move on. But this technology is also
Issuer: Mainz BioMed N.V. / Key word: Conference/Study results Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on...